The purposes of our study are: (i) to analyze the relationship between HMGA2 and the development of osteosarcoma; (ii) to provide a theoretical basis for the reversal of chemotherapy resistance of osteosarcoma; (iii) to elucidate HMGA2 as a potential therapeutic target of osteosarcoma. This evidence concerns the gene HMGA2 and osteosarcoma.